Designing a Multi-Epitope Vaccine against Human Cytomegalovirus: an Immunoinformatics Approach

“Cytomegalovirus (CMV) is identified as the most frequent inborn viral contagion in people and an important matter of morbidity and destruction in immunocompromised owners”. Cytomegalovirus is a typical herpes virus. Also distinguished as HCMV or human herpesvirus 5 (HHV-5). Once tainted, the human body holds the virus for life. CMV settles from person to person over body liquids, like blood, saliva, urine, semen and breast milk. “The Centers for Disease Control and Prevention organization” (CDC) predicted that around 50% of grown-ups in the United States have incurred the virus by forty years old. It afflicts men and women fairly, at any life and notwithstanding of ethnicity.

Fever, wetness, tiredness, restlessness, sore throat, enlarged glands, muscle strain, low desire and loss of weight are the obvious indications. But recurring and fundamental CMV have more dangerous symptoms and critical conditions like as jaundice, fever, pneumonia, cold, spots under the surface body, Purple color surface stains, a blemish, or all, developed liver, kidney, large spleen, low birth weight, breakdowns etc. Notwithstanding these debilitating maladies, no prescription to prevent them improvement or treatment is open till now.

That’s why we proposed to express a multi-epitope vaccine upon CMV by employing an Immuno bioinformatics road. For this desire, we practised the Human CMV spike protein to ascertain the dominant. After study of the specification of these epitopes we selected only six epitopes to create the desire vaccine against the human Cytomegalovirus. All features of a perfect vaccine was present of our designed vaccine such as non-toxin, non-allergenic and highly soluble etc.

Moreover, our created vaccine showed the excellent score in all physiochemical and in lifetimein the host cell.

Author(s):

Imran Hossain

Abstract | Full-Text | PDF

Share this